- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
From Polypharmacy to Personalized Care: Dr Nihar Desai Discusses Holistic Cardiovascular Care
In this episode of Managed Care Cast, Nihar Desai, MD, MPH, cardiologist and vice chief of Cardiology at the Yale School of Medicine, discusses therapies for cardiovascular conditions as they relate to patient adherence, polypharmacy, and health access.
Nihar R. Desai, MD, MPH, vice chief of cardiology at the Yale School of Medicine, joined The American Journal of Managed Care® to talk about critical topics in managing cardiovascular disease. He highlighted the importance of patient education, shared decision-making, and addressing cost and access barriers. Desai also explored multiple innovative strategies such as behavioral economics, personalized medicine, and digital tools to improve adherence.
He explained that a holistic approach to care is needed, particularly in addressing racial and ethnic disparities and integrating personalized medicine to achieve health equity. Additionally, he spoke on the promise of new therapies and the role of remote care in enhancing patient outcomes and quality of life.
Listen above or on one of these podcast services:
Insurance Payer Is Associated With Length of Stay After Traumatic Brain Injury
February 21st 2025Among hospitalized patients with traumatic brain injury, Medicaid fee-for-service was associated with longer hospital stays than private insurance and Medicaid managed care organizations.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
NSCLC Advancements Offer Hope, but Disparities Persist
February 20th 2025Ioana Bonta, MD, Georgia Cancer Specialists, discusses the evolving state of non-small cell lung cancer (NSCLC) treatments, their impact on patient outcomes, and the need to address ongoing disparities in these populations.
Read More
